ABK Biomedical is a company engaged in innovating next-generation embolotherapeutic products and delivery devices for the treatment of uterine fibroids, hypervascularized tumours, and arteriovenous malformations. The Company holds intellectual property in the focus area of inorganic polymer microspheres, targeted at the field of embolotherapy within the interventional radiology and interventional oncology medical disciplines.